In astrocytic tumors, Cx36 increases its levels inside tumor cells but decreases its expression in the environment depending on the tumor grade [134], which makes Cx36 a useful biomarker for tumor diagnosis and prediction of neoplasm progression. The gene discussed is GJD2; the disease is neoplasm.